Matthew Robson Email & Phone Number
Chief Medical Officer Japan, Novartis Innovative Medicines International @ Novartis
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Matthew Robson Location
- Tokyo, JP
Matthew Robson Work
- 2022 -now Chief Medical Officer Japan, Novartis Innovative Medicines International @
- 2020 -2022 Chief Scientific Officer, Novartis Pharma Japan @
- 2018 -2020 Global Head Medical Affairs, Cell and Gene Therapies Unit @
- 2017 -2018 Vice President, Hematology and CART, US Clinical Development and Medical Affairs @
- 2015 -2017 Vice President, Global Clinical Research, Immuno-Oncology @
- 2014 -2015 Clinical Head, Translational Clinical Oncology @
- 2011 -2014 Head, Oncology Translational Medicine Japan @
- 2010 -2011 Clinical Program Leader @
- 2007 -2010 Senior Global Clinical Leader @
- 2006 -2007 Director, Medical Safety Operations @
- 2005 -2006 Oncology Project Liaison, Clinical Quality Assurance @
- 2004 -2005 Medical Advisor @
- 1999 -2003 Risk Manager, Senior Medical Claims Handler @
- 1997 -1999 Fellow, Pediatric Hematology and Oncology @ Royal Children's Hospital, Melbourne
- 1996 -1997 Fellow, Bone Marrow Transplantation @ Bristol Royal Hospital for Children
Matthew Robson Education
- University of Bristol
MB ChB (Medicine)
1988-1993 - Repton School 1986-1988
Matthew Robson Skills
- Oncology drug development (phases I-III)
- FDA/EMA submission and approval
- People management in a cross-cultural setting
- Medical litigation
- Post-marketing safety
- Clinical quality assurance
- Classical piano
- Oncology
- Translational Medicine
- Clinical
- Clinical Development
- Protocol Development
- Clinical Trials
- Clinical Research
- GCP
- Biomarkers
- Taxi and restaurant Japanese
- Medicine
- Quality Assurance
- Drug Development
- Cancer
- Medical Affairs
- Medical Writing
- ICH-GCP
- Protocol
- CTMS
- Pediatrics
- Pharmacovigilance
- Pharmaceutical Industry
- Biotechnology
- Life Sciences
- Regulatory Submissions
- Therapeutic Areas
- Strategy
- Ich Gcp
- Oncology Drug Development Phases I Iii
- Sales
- Post Marketing Safety
- Fda/Ema Submission
- Strategic Planning
- Oncology Drug
- Clinical Quality
- Program Management
- Training
- Taxi And Restaurant
- People Management In A Cross Cultural Setting
- Project Management
- Oncology Drug Development
Matthew Robson Summary
- Matthew Robson, based in Tokyo, JP, is currently a Chief Medical Officer Japan, Novartis Innovative Medicines International at Novartis. Matthew Robson brings experience from previous roles at Novartis and Bristol-Myers Squibb. Matthew Robson holds a 1988 - 1993 MB ChB in Medicine @ University of Bristol. With a robust skill set that includes Oncology drug development (phases I-III), FDA/EMA submission and approval, People management in a cross-cultural setting, Medical litigation, Post-marketing safety and more. Matthew Robson has 1 emails on RocketReach.
Looking for a different Matthew Robson?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co